Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Pfizer’s Elrexfio accepted by SMC to treat relapsed and refractory multiple myeloma

Approximately 475 new cases of the disease are diagnosed in Scotland every year

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by MHRA to treat uncontrolled COPD

Approximately 1.4 million people in the UK have been diagnosed with the respiratory disease

- PMLiVE

Climate of Health: the prescription for survival

Addressing climate change as a health crisis

- PMLiVE

Answering some of Pharma’s big questions to drive brand strategies

By James Aird and Zoë van Helmond

Amiculum

- PMLiVE

Gilead and AI-focused Genesis partner to develop small molecule therapies

The companies will use Genesis’ AI platform to generate and optimise molecules for targets selected by Gilead

- PMLiVE

Merck and Daiichi Sankyo’s ADC candidate ifinatamab deruxtecan shows promise in SCLC

Approximately 70% of small cell lung cancer patients are diagnosed with extensive-stage disease

- PMLiVE

Sanofi/Regeneron announce positive late-stage results for Dupixent in chronic spontaneous urticaria

Detailed results from the confirmatory trial will be submitted to the FDA later this year

- PMLiVE

Supporting Mental Health on Suicide Prevention Day: Mednet’s Commitment to Changing the Narrative

As part of Suicide Prevention Day, we take a look at the different ways we can support our colleagues' mental health and wellbeing and change the narrative around suicide

Mednet

- PMLiVE

Eli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m

The companies will use Genetic Leap's AI platform to generate oligonucleotide drugs against targets selected by Lilly

- PMLiVE

GSK shares positive phase 3 results for long-acting biologic in severe asthma

Depemokimab is designed to allow for six-month dosing intervals for patients with the lung condition

regeneron headquarters

Regeneron’s Libtayo shows durable survival benefits in phase 3 lung cancer study

Non-small cell lung cancer accounts for up to 85% of all lung cancer cases

- PMLiVE

Avalere Health appoints Corrina Safeio as president, global marketing

Safeio will also serve as executive vice president, corporate communications, and on the leadership team

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links